Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in the western world, and the mortality rate from PCa in Asia has been increasing recently. Statins are potent inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and are commonly used for treating hyperlipidemi...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yu-An Chen, Ying-Ju Lin, Cheng-Li Lin, Hwai-Jeng Lin, Hua-Shan Wu, Hui-Ying Hsu, Yu-Chen Sun, Hui-Yu Wu, Chih-Ho Lai, Chia-Hung Kao
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2018-03-01
סדרה:	Frontiers in Pharmacology
נושאים:	hyperlipidemia HMG-CoA reductase prostate cancer statin cohort study
גישה מקוונת:	http://journal.frontiersin.org/article/10.3389/fphar.2018.00225/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!